CARPENTER ROBERT J 4
4 · Immuneering Corp · Filed Aug 4, 2021
Insider Transaction Report
Form 4
Immuneering CorpIMRX
CARPENTER ROBERT J
Director
Transactions
- Purchase
Class A Common Stock
2021-08-03$15.00/sh+325,000$4,875,000→ 1,148,839 total - Conversion
Series A Preferred Stock
2021-08-03−94,585→ 0 total→ Class A Common Stock (94,585 underlying) - Conversion
Series B Preferred Stock
2021-08-03−122,588→ 0 total→ Class A Common Stock (122,588 underlying) - Conversion
Class A Common Stock
2021-08-03+217,173→ 823,839 total
Footnotes (1)
- [F1]Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.